Can a new stent keep complex aortic aneurysms safely sealed?

NCT ID NCT07742254

ENROLLING_BY_INVITATION Disease control Sponsor: iVascular S.L.U. Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study looks at how well the iCover stent works when used as a bridging stent during a procedure called fenestrated endovascular aneurysm repair (fEVAR) for complex abdominal aortic aneurysms. The goal is to see if the stent stays open and keeps the aneurysm sealed without complications for up to a year. Researchers will review data from 154 patients who had this procedure at French hospitals, checking for safety and effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: iCover balloon-expandable covered stent
What this could lead to: If successful, this could support the safe and effective use of the iCover stent in complex aortic aneurysm repair, potentially improving outcomes for patients who need this procedure.
What could go wrong: This is a retrospective study, so it looks back at past procedures rather than testing the device in a controlled way. Results may be limited by the data available and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC ANEURYSM AORTIC ANEURYSM, ABDOMINAL

Contacts and locations

Locations

ARTER

Marseille, 13007, France
CHU Cavale Blanche, clinique en Cardiologie

Brest, 29609, France
CHU de Bordeaux, Chirurgie Vasculaire et Endovasculaire, Hôpital Pellegrin

Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.